Edition:
United States

Chimerix Inc (CMRX.OQ)

CMRX.OQ on NASDAQ Stock Exchange Global Market

5.46USD
24 Feb 2017
Change (% chg)

-- (--)
Prev Close
$5.46
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
127,108
52-wk High
$6.47
52-wk Low
$3.50

CMRX.OQ

Chart for CMRX.OQ

About

Chimerix, Inc. (Chimerix) is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing oral antivirals. The Company, based on its lipid conjugate technology, has developed its lead compound, brincidofovir (BCV, CMX001), which is in Phase III clinical development. In addition, the Company... (more)

Overall

Beta: 1.60
Market Cap(Mil.): $252.88
Shares Outstanding(Mil.): 46.32
Dividend: --
Yield (%): --

Financials

  CMRX.OQ Industry Sector
P/E (TTM): -- 44.08 29.63
EPS (TTM): -2.15 -- --
ROI: -30.17 -3.35 12.96
ROE: -30.20 5.80 14.11

BRIEF-Chimerix Q3 loss per share $0.37

* Chimerix inc- brincidofovir iv single and multiple dose data expected to report out in 2017

Nov 07 2016

More From Around the Web

Competitors

Earnings vs. Estimates